Sophoridine suppresses lenvatinib‐resistant hepatocellular carcinoma growth by inhibiting RAS/MEK/ERK axis via decreasing VEGFR2 expression-Reference-Cited by-同舟云学术

Sophoridine suppresses lenvatinib‐resistant hepatocellular carcinoma growth by inhibiting RAS/MEK/ERK axis via decreasing VEGFR2 expression

Published:2020-11-18 Issue:1 Volume:25 Page:549-560
ISSN:1582-1838
Container-title:Journal of Cellular and Molecular Medicine
language:en
Short-container-title:J. Cell. Mol. Med.

Author:

Zhao Zhongwei¹²,Zhang Dengke¹²,Wu Fazong¹²,Tu Jianfei¹²,Song Jingjing¹²,Xu Min¹²,Ji Jiansong¹²^ORCID

Affiliation:

1. Key Laboratory of Imaging Diagnosis and Minimally Invasive Intervention Research the Fifth Affiliated Hospital of Wenzhou Medical University /Affiliated Lishui Hospital of Zhejiang University/ The Central Hospital of Zhejiang Lishui Lishui China

2. Department of Radiology the Fifth Affiliated Hospital of Wenzhou Medical University /Affiliated Lishui Hospital of Zhejiang University/ The Central Hospital of Zhejiang Lishui Lishui China

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Cell Biology,Molecular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jcmm.16108

Reference35 articles.

1. Hepatocellular carcinoma

2. Hepatocellular Carcinoma

3. Hepatocellular carcinoma